HOME >> MEDICINE >> NEWS
Moderate alcohol consumption can act as a 'blood thinner'

Population studies have shown that moderate drinkers tend to have lower rates of heart disease but higher rates of bleeding-type strokes than abstainers. A potential mediator of these two contrasting effects of alcohol may be platelet function. A study in the October issue of Alcoholism: Clinical & Experimental Research confirms that moderate drinking has effects on blood coagulation primarily as a "blood thinner" which can have both positive and negative effects.

"The contrasting effects of alcohol are similar to the effects of blood thinners like aspirin, which clearly prevent heart attacks but at the expense of some additional bleeding strokes," said Kenneth J. Mukamal, an internist at Beth Israel Deaconess Medical Center and corresponding author for the study. "Acting as a blood thinner makes sense, because heart attacks are caused by blood clots that form in clogged arteries, and blood thinners can hasten bleeding from injured arteries. Based on these findings, we speculated that moderate drinking would also act as a blood thinner."

Mukamal added that previous research had shown that moderate drinkers tend to have "less sticky" platelets than abstainers, meaning that fewer blood elements cluster to form blood clots. "Yet no one before had looked at whether alcohol affects how easily platelets are activated," he said. "This is important because activated platelets are much stickier than normal ones."

In 1971, a total of 5,124 men and women enrolled in the Framingham Offspring Study of risk factors for cardiovascular disease the sons and daughters of participants in the original Framingham Heart Study. Participants have been examined and interviewed every four years since 1971, except for an eight-year interval between the first and second visits. This study uses data collected from 3,798 of those participants, examined between April 1, 1991 and March 1, 1994 (the fifth examination cycle); eventually analyzing data pro
'"/>


13-Oct-2005


Page: 1 2

Related medicine news :

1. Moderate drinking lowers womens risk of heart attack
2. Moderate alcohol intake associated with better mental function in older women
3. Moderate stress during pregnancy does not harm child development
4. Moderate drinking associated with better cognition in women
5. Moderately heavy models may actually lower womens self-esteem
6. Moderate to severe sleep-disordered breathing can lead to stroke
7. Moderate exercise yields cardiovascular benefits
8. Moderate to severe sleep apnea significantly raises stroke risk, study finds
9. Moderate alcohol use linked to increase in breast cancer risk
10. Brief motivational interviews work best long term for college students sent to alcohol counseling
11. Smoking may interfere with alcoholics neurocognitive recovery during abstinence

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Moderate alcohol consumption can act blood thinner

(Date:7/25/2014)... (PRWEB) July 25, 2014 AttorneyOne.com, a recognized ... latest information from the FDA on Ibuprofen and Oxcarbazepine ... that one lot of Ibuprofen and one lot of Oxcarbazepine ... due to mislabeled packaging. Oxcarbazepine is used for the treatment ... , The reason for the recall is that Lot ...
(Date:7/25/2014)... July 25, 2014 Parker Waichman LLP, ... of consumers comments on a recent tobacco lawsuit in ... smoker $23.6 billion in punitive damages. Cynthia Robinson brought ... cigarettes. The case is Cynthia Robinson v. R.J. Reynolds ... Florida First Circuit Court, Escambia County, Florida; Case Number ...
(Date:7/25/2014)... Drexel University College of Medicine is pleased ... been appointed vice dean for education, effective October 1, 2014. ... Medical College, where she is currently chair of the Department ... of medicine. , As a member of the senior ... major role in many aspects of the development of the ...
(Date:7/25/2014)... vulnerable neurons and reduce motor deficits in a ... University School of Medicine have shown. , The ... Parkinson,s Disease . , The findings demonstrate that ... at sufficient levels and have beneficial effects when ... Previous studies of XPro1595 in animals tested more ...
(Date:7/25/2014)... 25, 2014 The new report ... Feed, Pharmaceuticals and Others), by Type (Amylases, Cellulases, ... Geography - Global Trends & Forecasts to 2019", ... of the global Carbohydrase market with analysis of ... is segmented and values are forecasted on the ...
Breaking Medicine News(10 mins):Health News:Ibuprofen and Oxcarbazepine Tablets Recalled: AttorneyOne Monitors and Keep Consumers Informed 2Health News:A Florida Jury Awards Widow More Than $23 Billion in Punitive Damages in a Lawsuit Brought Against Tobacco Maker, R.J. Reynolds, Parker Waichman LLP Comments 2Health News:A Florida Jury Awards Widow More Than $23 Billion in Punitive Damages in a Lawsuit Brought Against Tobacco Maker, R.J. Reynolds, Parker Waichman LLP Comments 3Health News:Valerie D. Weber, MD, Appointed Vice Dean for Education at Drexel University College of Medicine 2Health News:Valerie D. Weber, MD, Appointed Vice Dean for Education at Drexel University College of Medicine 3Health News:Anti-inflammatory drug can prevent neuron loss in Parkinson's model 2Health News:Carbohydrase Market worth $3,717.7 Million by 2019 - Report by MarketsandMarkets 2Health News:Carbohydrase Market worth $3,717.7 Million by 2019 - Report by MarketsandMarkets 3Health News:Carbohydrase Market worth $3,717.7 Million by 2019 - Report by MarketsandMarkets 4
(Date:7/24/2014)... 24, 2014  Uroplasty, Inc. (NASDAQ: UPI ... and markets innovative proprietary products to treat voiding ... 2015 first quarter ended June 30, 2014.  ... Neuromodulation System grew 19% to $4.1 million, as ... of the prior year.  Total revenue for the ...
(Date:7/24/2014)... July 24, 2014 Amgen (NASDAQ: AMGN ... financial results on Tuesday, July 29, 2014, after the close ... by a conference call with the investment community at 2 ... Robert A. Bradway , chairman and chief executive officer, ... Live audio of the conference call will be simultaneously broadcast ...
(Date:7/24/2014)... British Columbia and MENLO PARK, Calif. ... Inc. (OTCQB: DMPI) ("DelMar" "the company") announced today that ... company,s fiscal year from December 31 to June 30. Accordingly, ... September 30, 2014. Jeffrey Bacha , president ... end is an important step in achieving our goal of ...
Breaking Medicine Technology:Uroplasty Reports Fiscal First Quarter Results 2Uroplasty Reports Fiscal First Quarter Results 3Uroplasty Reports Fiscal First Quarter Results 4Uroplasty Reports Fiscal First Quarter Results 5Uroplasty Reports Fiscal First Quarter Results 6Uroplasty Reports Fiscal First Quarter Results 7Uroplasty Reports Fiscal First Quarter Results 8Uroplasty Reports Fiscal First Quarter Results 9Uroplasty Reports Fiscal First Quarter Results 10Uroplasty Reports Fiscal First Quarter Results 11Amgen Announces Webcast of 2014 Second Quarter Financial Results 2DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial 2DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial 3
Cached News: